2026.Apr.02
Corporate
OBI Participated in BIO-Europe Spring®, Advancing International Business Development
Engaged with Multiple Global Pharma Companies for Licensing Discussions
OBI Pharma (4174.TWO) recently participated in BIO-Europe Spring® held in Lisbon, Portugal, another key international partnering event for the biotechnology industry. Through its participation, OBI accelerated its international business development, enhanced its global visibility, and advanced multiple partnership opportunities into advanced evaluation stages.
This article is password protected.
To view the content, please enter your password in the field below